Regarding the effects of selenium in cancer treatment, a study [56] sought to assess whether selenium supplementation could attenuate the progression of prostate cancer by administering daily doses of 0 μg, 200 μg, and 800 μg of selenium to prostate cancer patients, with PSA velocity used as a measurement parameter. The gene discussed is KLK3; the disease is prostate cancer.